Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03477695
Other study ID # ASMC-17-NG-0728-CTIL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2018
Est. completion date December 31, 2019

Study information

Verified date March 2018
Source Tel-Aviv Sourasky Medical Center
Contact Marina Brozgol
Phone +97236947513
Email marina.brozgol@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A stooped posture is one of the characteristic motor symptoms of patients with Parkinson's disease, and has been linked to impairments in ADL and QOL. We aimed to test the efficacy, safety, practical utility and user-friendliness of a posture correction and vibrotactile trunk angle feedback device (the UpRight) in the home setting of patients with Parkinson's disease with a stooped posture.


Description:

The subjects will be asked to arrive at the Gait laboratory for Mobility Research at Tel Aviv Medical Center. After a detailed explanation of the research procedure and after signing the consent form, they will be introduced to the UPRIGHT GO device. Participances will practice operating and placing the device on the body.

With the device attached to upper back, a number of short clinical tests will be performed:

1. Complete demographic questionnaires and medical history

2. Walking tests and balance:

1. Short walks at a comfortable speed with or without dual task.

2. Stairs

3. Performing daily tasks, such as entering and exiting a room, negotiating obstacles (shoebox), walking between obstacles, buttons, tying laces, carrying small objects on a tray, bringing a glass of water etc.

4. Timed "Get up and go test" All tests are supervised by a physiotherapist .

Upon completion of the tests, the UPRIGHT device will be delivered for use and exercise for 2 months. Physiotherapist will guide to maintain the devices (such as charging devices and connecting to power).

At the end of the training period, the participans will be invited again to Gait Lab for post tests.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 50 Years to 90 Years
Eligibility Inclusion criteria:

1. Diagnosis of Parkinson's disease, as defined in the UK Brain Bank criteria

2. Hoehn and Yahr stage I-III

3. Participants who are at stable medication regimen

4. Able to walk independently for at least 5 minutes with or without support of accessory device.

Exclusion criteria:

1. Mini Mental State Exam (MMSE) score< 24

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ambulatory use of the Upright device
Patients will wear the UpRight for a period of two month

Locations

Country Name City State
Israel Laboratory for gait and neurodynamics, Tel-Aviv Sourasky Medical Center Tel-Aviv

Sponsors (1)

Lead Sponsor Collaborator
Tel-Aviv Sourasky Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (1)

van Wegen EEH, de Goede CJT, Kwakkel G, van Kordelaar J. Sensor assisted self-management in Parkinson's disease: A feasibility study of ambulatory posture detection and feedback to treat stooped posture. Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S57-S61. doi: 10.1016/j.parkreldis.2017.07.024. Epub 2017 Jul 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Average trunk angle in the sagittal plane using a Postural Analysis Chart Postural Analysis 8 weeks
Secondary Patient satisfaction by VAS scores Results for the VAS scores with possible range 0 (worst) to 10 (best) 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT06037590 - A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA® Phase 1
Enrolling by invitation NCT04799418 - STEM-PD Open Label Extension (OLE) N/A
Not yet recruiting NCT06074393 - Caregiving in Advanced PD: A Tailored Support Group N/A
Completed NCT05699161 - Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson Phase 1/Phase 2
Not yet recruiting NCT05599659 - The Calgary Movement Disorders Advanced Care Pilot Program N/A
Completed NCT04140708 - Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease N/A
Recruiting NCT03924414 - Trial of Parkinson's And Zoledronic Acid Phase 4
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Not yet recruiting NCT06400017 - Mechanism and Application of DBS in the Treatment of PD N/A
Recruiting NCT04797611 - STEM-Parkinson's Disease N/A
Not yet recruiting NCT06174948 - The Use of the CUE1 in People With Parkinson's Disease and Related Disorders N/A
Recruiting NCT05934747 - Aim 3 Particle Swarm Optimization PIGD N/A
Enrolling by invitation NCT04701177 - Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
Recruiting NCT05962489 - Sleep-specific DBS Therapy in Parkinson's Disease N/A
Recruiting NCT05931692 - Virtual Reality and Fear of Falling in Parkinson's Disease
Recruiting NCT04468919 - Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit N/A
Completed NCT04925622 - Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Recruiting NCT04214509 - LIPAD - LRRK2 International Parkinson's Disease Study
Active, not recruiting NCT05677633 - Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease Phase 1
Recruiting NCT06350617 - Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients N/A